Abstract
Castration-resistant metastatic prostate cancer (CRPC) is an incurable disease, a large number of studies have been looking for therapeutic alternatives based on the molecular pathways that act in this phase of the neoplasia. Alterations in the androgen receptor occur frequently in the progression of this neoplasia and the androgen receptor cofactors appear as attractive molecules, since …